Download PDF
Fortschr Neurol Psychiatr 2003; 71(8): 423-440
DOI: 10.1055/s-2003-41196
Fort- und Weiterbildung
© Georg Thieme Verlag Stuttgart · New York

Diagnostik und Therapie des akuten Schlaganfalls

Diagnostics and Treatment of Acute StrokeP.  D.  Schellinger1 , J.  B.  Fiebach2
  • 1Neurologische Klinik und
  • 2Neuroradiologie der Universität Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg
Further Information

Publication History

Publication Date:
11 August 2003 (online)

    Permissions and Reprints

Weiterbildungsziele

In diesem Beitrag sollen folgende Weiterbildungsziele vermittelt werden:

1. Lernziele

2. Einleitung

3. Allgemeine Maßnahmen
3.1 Thrombozytenaggregationshemmer, Antikoagulanzien, Defibrogenisierung, GP IIb/IIIa Antagonisten
3.2 Thrombolyse
3.3 Intravenöse Thrombolyse

4. Metaanalysen

5. Aktuelle Entwicklungen

6. Diagnostik des akuten Schlaganfalls mit dem MRT (S-MRT)

7. S-MRT und ICB

8. Vergleich von S-MRT und CT bei der Diagnostik zerebraler Ischämien

9. Das S-MRT bei intravenöser Thrombolyse

Literatur

  • 1 WHO Task Force . Stroke - 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.  Stroke. 1989;  20 1407-1431
    CrossrefPubMedGoogle Scholar
  • 2 The European Stroke Initiative . Recommendations for Stroke Management.  Cerebrovasc Dis. 2000;  10 1-34
    PubMedGoogle Scholar
  • 3 Astrup J, Siesjö B, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra.  Stroke. 1981;  12 723-725
    CrossrefPubMedGoogle Scholar
  • 4 Schellinger P D, Fiebach J B, Mohr A. et al . Thrombolytic therapy for ischemic stroke-A review. Part I-Intravenous thrombolysis.  Crit Care Med. 2001;  29 1812-1818
    PubMedGoogle Scholar
  • 5 Hacke W, Kaste M, Olsen T S. et al . European Stroke Initiative (EUSI) Recommendations for Stroke Management.  Cerebrovasc Dis. 2000;  in press
    PubMedGoogle Scholar
  • 6 Schellinger P, Steiner T. Emergency and intensive-care treatment after a stroke. Recommendations of the European Consensus Group.  Nervenarzt. 1998;  69 530-539
    CrossrefPubMedGoogle Scholar
  • 7 Broderick J, Brott T, Barsan W. et al . Blood pressure during the first minutes of focal cerebral ischemia.  Ann Emerg Med. 1993;  22 1438-1443
    PubMedGoogle Scholar
  • 8 Brott T, Fieschi C, Hacke W. General therapy of ischemic stroke. In: Hacke W (ed). Neurocritical care. Berlin/Heidelberg: Springer-Verlag 1994: 553-577
    Google Scholar
  • 9 Reith J, Jorgensen H S, Pedersen P M. et al . Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome.  Lancet. 1996;  347 422-425
    CrossrefPubMedGoogle Scholar
  • 10 Grau A J, Buggle F, Hacke W. Body temperature and infection in acute stroke.  Lancet. 1996;  347 1415-1416
    PubMedGoogle Scholar
  • 11 Weir C J, Murray G D, Dyker A G. et al . Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study.  Bmj. 1997;  314 1303-1306
    CrossrefPubMedGoogle Scholar
  • 12 Albers G W, Amarenco P, Easton J D. et al . Anthithrombotic and Thrombolytic Therapy for Ischemic Stroke.  Chest. 2001;  119 300S-320S
    CrossrefPubMedGoogle Scholar
  • 13 Adams Jr H P, Adams R J, Brott T. et al . Guidelines for the early management of patients with ischemic stroke: a scientific statement from the stroke council of the american stroke association.  Stroke. 2003;  34 1056-1083
    CrossrefPubMedGoogle Scholar
  • 14 International Stroke Trial Collaborative Group . The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both or neither among 19 435 patients with acute ischaemic stroke.  Lancet. 1997;  349 1569-1581
    CrossrefPubMedGoogle Scholar
  • 15 Hacke W. Abciximab in Emergent Stroke Treatment Trial (Abestt). International Stroke Conference, Phoenix, AZ, USA. February 13th-15th, 2003
    Google Scholar
  • 16 Schellinger P D, Fiebach J B, Ringleb P A. et al . [Thrombolytic therapy in ischemic stroke].  Nervenarzt. 2001;  72 590-599
    CrossrefPubMedGoogle Scholar
  • 17 Schellinger P D, Fiebach J B, Mohr A. et al . Thrombolytic therapy for ischemic stroke-A review. Part II-Intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging.  Crit Care Med. 2001;  29 1819-1825
    PubMedGoogle Scholar
  • 18 Brandt T, Kummer R von, Muller Kuppers M. et al . Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome.  Stroke. 1996;  27 875-881
    CrossrefPubMedGoogle Scholar
  • 19 Wardlaw J M, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke (Cochrane Review). The Cochrane Library. 2002
    Google Scholar
  • 20 Hacke W, Kaste M, Fieschi C. et al . Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study.  JAMA. 1995;  274 1017-1025
    CrossrefPubMedGoogle Scholar
  • 21 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group . Tissue plasminogen activator for acute ischemic stroke.  N Engl J Med. 1995;  333 1581-1587
    CrossrefPubMedGoogle Scholar
  • 22 Hacke W, Kaste M, Fieschi C. et al . Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II).  Lancet. 1998;  352 1245-1251
    CrossrefPubMedGoogle Scholar
  • 23 Clark W M, Wissman S, Albers G W. et al . Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.  Jama. 1999;  282 2019-2026
    CrossrefPubMedGoogle Scholar
  • 24 Steiner T, Bluhmki E, Kaste M. et al . The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification.  Cerebrovasc Dis. 1998;  8 198-203
    PubMedGoogle Scholar
  • 25 Stingele R, Bluhmki E, Hacke W. Bootstrap statistics of ECASS II data: just another post hoc analysis of a negative stroke trial?.  Cerebrovasc Dis. 2001;  11 30-33
    PubMedGoogle Scholar
  • 26 Hacke W, Brott T, Caplan L. et al . Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.  Neurology. 1999;  53 S3-14
    PubMedGoogle Scholar
  • 27 Brott T G. A combined metaanalysis of NINDS, ECASS I and II, ATLANTIS. International Stroke Conference, San Antonio, TX, USA. February 7 - 9th, 2002
    Google Scholar
  • 28 Katzan I L, Furlan A J, Lloyd L E. et al . Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.  Jama. 2000;  283 1151-1158
    CrossrefPubMedGoogle Scholar
  • 29 Kummer R von, Bozzao L, Manelfe C. Early CT diagnosis of hemispheric brain infarction. Heidelberg: Springer 1995
    Google Scholar
  • 30 Mohr J P, Biller J, Hilal S K. et al . Magnetic resonance versus computed tomographic imaging in acute stroke.  Stroke. 1995;  26 807-812
    PubMedGoogle Scholar
  • 31 Hacke W, Warach S. Diffusion-weighted MRI as an evolving standard of care in acute stroke.  Neurology. 2000;  54 1548-1549
    PubMedGoogle Scholar
  • 32 Fiebach J B, Schellinger P D. Modern Magnetic Resonance Techniques with Stroke.  Nervenarzt. 2002;  73 104-117
    CrossrefPubMedGoogle Scholar
  • 33 Warach S, Boska M, Welch K M. Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke.  Stroke. 1997;  28 481-482
    PubMedGoogle Scholar
  • 34 Schellinger P D, Fiebach J B, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status.  Stroke. 2003;  34 575-583
    CrossrefPubMedGoogle Scholar
  • 35 Fiebach J B, Schellinger P D, Jansen O. et al . CT and diffusion-weighted MR-Imaging in randomized order: DWI results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke.  Stroke. 2002;  33 2206-2210
    CrossrefPubMedGoogle Scholar
  • 36 Fiehler J, Fiebach J B, Gass A. et al . Diffusion Weighted Imaging in Acute Stroke - A Tool of Uncertain Value.  Cerebrovasc Dis. 2001;  14 187-196
    PubMedGoogle Scholar
  • 37 Fiehler J, Foth M, Kucinski T. et al . Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans.  Stroke. 2002;  33 79-86
    CrossrefPubMedGoogle Scholar
  • 38 Schellinger P D, Fiebach J B, Jansen O. et al . Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia.  Ann Neurol. 2001;  49 460-469
    CrossrefPubMedGoogle Scholar
  • 39 Gass A, Röther J, Gaa J. Diffusion- and Perfusion-Weighted MRI in Cerebral Ischaemia - Part 2: Clinical Applications.  Akt Neurol. 1999;  26 309-317
    PubMedGoogle Scholar
  • 40 Röther J, Gass A, Busch E. Diffusion- and Perfusion-Weighted MRI in Cerebral Ischaemia - Part 1: Results of Animal Experiments.  Akt Neurol. 1999;  26 300-308
    PubMedGoogle Scholar
  • 41 Schellinger P D, Jansen O, Fiebach J B. et al . Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute Ischemic Stroke with Diffusion and Perfusion MRI.  Stroke. 2000;  31 1318-1328
    PubMedGoogle Scholar
  • 42 Marks M P, Tong D, Beaulieu C. et al . Evaluation of early reperfusion and IV rt-PA therapy using diffusion- and perfusion-weighted MRI.  Neurology. 1999;  52 1792-1798
    PubMedGoogle Scholar
  • 43 Kidwell C S, Saver J L, Mattiello J. et al . Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging.  Ann Neurol. 2000;  47 462-469
    CrossrefPubMedGoogle Scholar
  • 44 Powers W J, Zivin J. Magnetic resonance imaging in acute stroke: not ready for prime time.  Neurology. 1998;  50 842-843
    PubMedGoogle Scholar
  • 45 Schellinger P D, Jansen O, Fiebach J B. et al . Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia.  AJNR Am J Neuroradiol. 2000;  21 1184-1189
    PubMedGoogle Scholar
  • 46 Warach S. Stroke neuroimaging.  Stroke. 2003;  34 345-347
    CrossrefPubMedGoogle Scholar
  • 47 Schellinger P D, Fiebach J B, Mohr A. et al . The role of stroke MRI in intracranial and subarachnoid hemorrhage.  Nervenarzt. 2001;  72 907-917
    CrossrefPubMedGoogle Scholar
  • 48 Linfante I, Llinas R H, Caplan L R. et al . MRI features of intracerebral hemorrhage within 2 hours from symptom onset.  Stroke. 1999;  30 2263-2267
    PubMedGoogle Scholar
  • 49 Schellinger P D, Jansen O, Fiebach J B. et al . A Standardized MRI Stroke Protocol: Comparison with CT in Hyperacute Intracerebral Hemorrhage.  Stroke. 1999;  30 765-768
    PubMedGoogle Scholar
  • 50 Fiebach J B, Schellinger P D, Gass A. et al . Stroke MRI is accurate in hyperacute intracerebral hemorrhage. A multicenter study on the validity of stroke imaging.  Lancet. 2003;  submitted for publication
    PubMedGoogle Scholar
  • 51 Kummer R von, Allen K L, Holle R. et al . Acute stroke: usefulness of early CT findings before thrombolytic therapy.  Radiology. 1997;  205 327-333
    PubMedGoogle Scholar
  • 52 Jansen O, Schellinger P D, Fiebach J B. et al . Early recanalization in acute ischemic stroke saves tissue at risk defined by MRI.  Lancet. 1999;  353 2036-2037
    CrossrefPubMedGoogle Scholar
  • 53 Röther J, Schellinger P D, Gass A. et al . Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute Stroke <6h.  Stroke. 2002;  33 2438-2445
    CrossrefPubMedGoogle Scholar
  • 54 Külkens S, Schwark C, Schellinger P D. et al .Thrombolysis in ischemic stroke 3 to 6 hours after symptom onset using a MR-based algorithm. International Stroke Conference, Phoenix, AZ, USA. February 13 - 15th, 2003
    Google Scholar

Priv.-Doz. Dr. med. Peter D. Schellinger

Neurologische Klinik des Universitätsklinikums Heidelberg

Im Neuenheimer Feld 400 - Kopfklinik

69120 Heidelberg

Email: Peter_Schellinger@med.uni-heidelberg.de

      >